John R. Moore - May 16, 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
General Counsel
Signature
/s/ John R. Moore
Stock symbol
EWTX
Transactions as of
May 16, 2022
Transactions value $
-$80,146
Form type
4
Date filed
5/18/2022, 05:15 PM
Previous filing
May 3, 2022
Next filing
Jun 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Sale -$80.1K -10.8K -78.26% $7.42 3K May 16, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022.
F2 The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $7.11 to $8.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes 1,438 shares purchased on May 16, 2022 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.